These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21206026)

  • 21. Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization.
    Liu S; Leppla SH
    J Biol Chem; 2003 Feb; 278(7):5227-34. PubMed ID: 12468536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential dependence on N-glycosylation of anthrax toxin receptors CMG2 and TEM8.
    Friebe S; Deuquet J; van der Goot FG
    PLoS One; 2015; 10(3):e0119864. PubMed ID: 25781883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of receptor-based inhibitory RNA aptamers for anthrax toxin neutralization.
    Lee SC; Gedi V; Ha NR; Cho JH; Park HC; Yoon MY
    Int J Biol Macromol; 2015; 77():293-302. PubMed ID: 25841381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects from metal ion in tumor endothelial marker 8 and anthrax protective antigen: BioLayer Interferometry experiment and molecular dynamics simulation study.
    Jia Z; Ackroyd C; Han T; Agrawal V; Liu Y; Christensen K; Dominy B
    J Comput Chem; 2017 Jun; 38(15):1183-1190. PubMed ID: 28437008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a receptor-based inhibitory penta-unit-conjugated peptide to enhance anthrax toxin neutralization.
    Lee SC; Yoon MY
    Int J Biol Macromol; 2020 Nov; 163():327-335. PubMed ID: 32619663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the interaction between anthrax toxin and its cellular receptors.
    Liu S; Leung HJ; Leppla SH
    Cell Microbiol; 2007 Apr; 9(4):977-87. PubMed ID: 17381430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor.
    Li L; Guo Q; Liu J; Zhang J; Yin Y; Dong D; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26805881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism.
    Kintzer AF; Sterling HJ; Tang II; Williams ER; Krantz BA
    PLoS One; 2010 Nov; 5(11):e13888. PubMed ID: 21079738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Disulfide Bond Cys255-Cys279 in the Immunoglobulin-Like Domain of Anthrax Toxin Receptor 2 Is Required for Membrane Insertion of Anthrax Protective Antigen Pore.
    Jacquez P; Avila G; Boone K; Altiyev A; Puschhof J; Sauter R; Arigi E; Ruiz B; Peng X; Almeida I; Sherman M; Xiao C; Sun J
    PLoS One; 2015; 10(6):e0130832. PubMed ID: 26107617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo.
    Scobie HM; Wigelsworth DJ; Marlett JM; Thomas D; Rainey GJ; Lacy DB; Manchester M; Collier RJ; Young JA
    PLoS Pathog; 2006 Oct; 2(10):e111. PubMed ID: 17054395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of filamentous actin to anthrax toxin receptor 1 decreases its association with protective antigen.
    Garlick KM; Batty S; Mogridge J
    Biochemistry; 2012 Feb; 51(6):1249-56. PubMed ID: 22303962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2.
    Verma A; Moayeri M; Mocca CP; O'Mard D; Ma Q; Leppla SH; Burns DL
    Vaccine; 2022 Jul; 40(32):4318-4321. PubMed ID: 35710508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-range stabilization of anthrax protective antigen upon binding to CMG2.
    Mullangi V; Mamillapalli S; Anderson DJ; Bann JG; Miyagi M
    Biochemistry; 2014 Sep; 53(38):6084-91. PubMed ID: 25186975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capillary morphogenesis gene 2 (CMG2) mediates growth factor-induced angiogenesis by regulating endothelial cell chemotaxis.
    Cryan LM; Tsang TM; Stiles J; Bazinet L; Lee SL; Garrard S; Madrian E; Roberts C; Payne J; Jensen A; Frankel AE; Ackroyd PC; Christensen KA; Rogers MS
    Angiogenesis; 2022 Aug; 25(3):397-410. PubMed ID: 35212873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anthrax toxin: receptor binding, internalization, pore formation, and translocation.
    Young JA; Collier RJ
    Annu Rev Biochem; 2007; 76():243-65. PubMed ID: 17335404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anthrax toxin receptor 1/tumor endothelial marker 8: mutation of conserved inserted domain residues overrides cytosolic control of protective antigen binding.
    Ramey JD; Villareal VA; Ng C; Ward SC; Xiong JP; Clubb RT; Bradley KA
    Biochemistry; 2010 Aug; 49(34):7403-10. PubMed ID: 20690680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The protective antigen component of anthrax toxin forms functional octameric complexes.
    Kintzer AF; Thoren KL; Sterling HJ; Dong KC; Feld GK; Tang II; Zhang TT; Williams ER; Berger JM; Krantz BA
    J Mol Biol; 2009 Sep; 392(3):614-29. PubMed ID: 19627991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicity of anthrax toxin is influenced by receptor expression.
    Taft SC; Weiss AA
    Clin Vaccine Immunol; 2008 Sep; 15(9):1330-6. PubMed ID: 18596206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton.
    Werner E; Kowalczyk AP; Faundez V
    J Biol Chem; 2006 Aug; 281(32):23227-36. PubMed ID: 16762926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anthrax toxin uptake by primary immune cells as determined with a lethal factor-beta-lactamase fusion protein.
    Hu H; Leppla SH
    PLoS One; 2009 Nov; 4(11):e7946. PubMed ID: 19956758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.